AAM
AGN

Alpine Associates Management’s Allergan plc AGN Stock Holding History

Alpine Associates Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-110,600
Closed -$29.6M – 73
2016
Q1 		$29.6M Buy
+110,600
New +$31.7M 1.02% 34

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Alpine Associates Management's AGN Position: Q2 2020 in Review

Alpine Associates Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 799,632 shares — an estimated $142M sold.

Alpine Associates Management first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $195M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Alpine Associates Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Alpine Associates Management sold 799,632 Allergan plc shares in Q2 2020, an estimated $142M.
  • Alpine Associates Management first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Alpine Associates Management's Allergan plc position peaked at $195M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Alpine Associates Management's 13F filing for Q2 2020, filed 12 Aug 2020.